Ingenol Disoxate

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameIngenol Disoxate
Drug Alias Nameingenoli disoxas巨大戟醇地索酯disoxato de ingenol英吉地酯LEO-43204
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinase C stimulantsApoptosis stimulants
TargetsNot applicable
Therapy Area/IndicationsAcne VulgarisKeratosis, ActinicCarcinoma, Squamous Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesAustralia +[7
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLeo Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLeo Pharma Inc
Active IndicationsN/A
Inactive IndicationsAcne VulgarisKeratosis, ActinicCarcinoma, Squamous Cell

Other Information

ATC CodeN/A
Related LinksN/A